Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dorothy Crawford

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Procedures

Concepts & Ideas

Risk Factors

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
17
Haque, Tanzina
11
McAulay, Karen
11
Thomas, Alero
9
Swerdlow, Anthony
8
Higgins, Craig
7
Macsween, Karen
7
Wilkie, Gwen
7
Williams, Hilary
6
Johannessen, Ingolfur
5
Harrison, Nadine
5
Amlot, Peter
3
Burns, David
3
Conacher, Margaret
3
Hopwood, Paul
3
Reid, Stuart

Sign-in to see all Coauthors

Publications

TOP 3
McAulay K A; Haque T; Crawford D H
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.
Vanhoutte Victoria J; McAulay Karen A; McCarrell Erin; Turner Marc; Crawford Dorothy H; Haque Tanzina
Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
Wingate P J; McAulay K A; Anthony I C; Crawford D H
Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dorothy Crawford (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: McAulay K A; Haque T; Crawford D H
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.
British journal of cancer 2009;101(6):1019-27.
2009: Vanhoutte Victoria J; McAulay Karen A; McCarrell Erin; Turner Marc; Crawford Dorothy H; Haque Tanzina
Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
Immunology 2009;127(4):577-86.
2009: Wingate P J; McAulay K A; Anthony I C; Crawford D H
Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Journal of medical virology 2009;81(5):870-7.
2009: McAulay Karen A; Haque Tanzina; Urquhart Gillian; Bellamy Christopher; Guiretti Deisy; Crawford Dorothy H
Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(6):3892-901.
2007: McAulay Karen A; Higgins Craig D; Macsween Karen F; Lake Annette; Jarrett Ruth F; Robertson Faye L; Williams Hilary; Crawford Dorothy H
HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.
The Journal of clinical investigation 2007;117(10):3042-8.
2007: Haque Tanzina; Wilkie Gwen M; Jones Marie M; Higgins Craig D; Urquhart Gillian; Wingate Phoebe; Burns David; McAulay Karen; Turner Marc; Bellamy Christopher; Amlot Peter L; Kelly Deirdre; MacGilchrist Alastair; Gandhi Maher K; Swerdlow Anthony J; Crawford Dorothy H
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.
Blood 2007;110(4):1123-31.
2007: Gandhi M K; Wilkie G M; Dua U; Mollee P N; Grimmett K; Williams T; Whitaker N; Gill D; Crawford D H
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1293-9.
2007: Higgins Craig D; Swerdlow Anthony J; Macsween Karen F; Harrison Nadine; Williams Hilary; McAulay Karen; Thomas Ranjit; Reid Stuart; Conacher Margaret; Britton Kathryn; Crawford Dorothy H
A study of risk factors for acquisition of Epstein-Barr virus and its subtypes.
The Journal of infectious diseases 2007;195(4):474-82.
2006: Haque Tanzina; Johannessen Ingolfur; Dombagoda Dilani; Sengupta Chandrya; Burns David M; Bird Pru; Hale Geoff; Mieli-Vergani Giorgina; Crawford Dorothy H
A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.
The Journal of infectious diseases 2006;194(5):584-7.
2006: Thomas Ranjit; Macsween Karen F; McAulay Karen; Clutterbuck Daniel; Anderson Richard; Reid Stuart; Higgins Craig D; Swerdlow Anthony J; Harrison Nadine; Williams Hilary; Crawford Dorothy H
Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions.
Journal of medical virology 2006;78(9):1204-9.
2006: Crawford Dorothy H; Macsween Karen F; Higgins Craig D; Thomas Ranjit; McAulay Karen; Williams Hilary; Harrison Nadine; Reid Stuart; Conacher Margaret; Douglas Jill; Swerdlow Anthony J
A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(3):276-82.
2006: Williams Hilary; Crawford Dorothy H
Epstein-Barr virus: the impact of scientific advances on clinical practice.
Blood 2006;107(3):862-9.
2005: Conacher Margaret; Callard Robin; McAulay Karen; Chapel Helen; Webster David; Kumararatne Dinakantha; Chandra Anita; Spickett Gavin; Hopwood Paul A; Crawford Dorothy H
Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.
Journal of virology 2005;79(17):11128-34.
2005: Thomas Ranjit V; McAulay Karen; Higgins Craig; Wilkie Gwen; Crawford Dorothy H
Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease.
Blood 2005;106(4):1502-3; author reply 1503.
2005: Wynn Robert F; Arkwright Peter D; Haque Tanzina; Gharib Maged I; Wilkie Gwen; Morton-Jones Marie; Crawford Dorothy H
Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.
The lancet oncology 2005;6(5):344-6.
2005: Williams Hilary; McAulay Karen; Macsween Karen F; Gallacher Neil J; Higgins Craig D; Harrison Nadine; Swerdlow Anthony J; Crawford Dorothy H
The immune response to primary EBV infection: a role for natural killer cells.
British journal of haematology 2005;129(2):266-74.
2004: Talbot Simon J; Crawford Dorothy H
Viruses and tumours--an update.
European journal of cancer (Oxford, England : 1990) 2004;40(13):1998-2005.
2004: Burns David M; Crawford Dorothy H
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Blood reviews 2004;18(3):193-209.
2004: Wilkie Gwen M; Taylor Clare; Jones Marie M; Burns David M; Turner Marc; Kilpatrick David; Amlot Peter L; Crawford Dorothy H; Haque Tanzina
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(4):309-16.
2003: Higgins Craig D; Swerdlow Anthony J; Smith John D; Hunt Beverley J; Thomas J Alero; Burke Margaret M; Crawford Dorothy H; Yacoub Magdi H
Risk of lymphoid neoplasia after cardiothoracic transplantation: the influence of underlying disease and human leukocyte antigen type and matching.
Transplantation 2003;75(10):1698-703.
2003: Macsween Karen F; Crawford Dorothy H
Epstein-Barr virus-recent advances.
The Lancet infectious diseases 2003;3(3):131-40.
2002: Crawford Dorothy H; Swerdlow Anthony J; Higgins Craig; McAulay Karen; Harrison Nadine; Williams Hilary; Britton Kathryn; Macsween Karen F
Sexual history and Epstein-Barr virus infection.
The Journal of infectious diseases 2002;186(6):731-6.
2002: Haque Tanzina; Wilkie Gwen M; Taylor Clare; Amlot Peter L; Murad Parvez; Iley Angela; Dombagoda Dilani; Britton Kate M; Swerdlow Anthony J; Crawford Dorothy H
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
Lancet 2002;360(9331):436-42.
2002: Hopwood Paul A; Brooks Louise; Parratt Rachael; Hunt Beverly J; Bokhari Maria; Thomas J Alero; Yacoub Magdi; Crawford Dorothy H;
Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.
Transplantation 2002;74(2):194-202.
2002: Johannessen Ingolfur; Perera Sunimali M; Gallagher Alice; Hopwood Paul A; Thomas J Alero; Crawford Dorothy H
Expansion in scid mice of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease biopsy material.
The Journal of general virology 2002;83(Pt 1):173-8.
2001: Haque T; Taylor C; Wilkie G M; Murad P; Amlot P L; Beath S; McKiernan P J; Crawford D H
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.
Transplantation 2001;72(8):1399-402.
2000: Johannessen I; Asghar M; Crawford D H
Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice.
British journal of haematology 2000;109(3):600-10.
2000: Hopwood P; Crawford D H
The role of EBV in post-transplant malignancies: a review.
Journal of clinical pathology 2000;53(4):248-54.
2000: Faulkner G C; Krajewski A S; Crawford D H
The ins and outs of EBV infection.
Trends in microbiology 2000;8(4):185-9.
2000: Swerdlow A J; Higgins C D; Hunt B J; Thomas J A; Burke M M; Crawford D H; Yacoub M H
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.
Transplantation 2000;69(5):897-904.
1999: Johannessen I; Crawford D H
In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD).
Reviews in medical virology 1999;9(4):263-77.
1999: Haque T; Crawford D H
The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation.
British journal of haematology 1999;106(2):309-16.
1999: Faulkner G C; Burrows S R; Khanna R; Moss D J; Bird A G; Crawford D H
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.
Journal of virology 1999;73(2):1555-64.
1998: Johannessen I; Haque T; N'Jie-Jobe J; Crawford D H
Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.
The Journal of general virology 1998;79 ( Pt 7)():1631-6.
1998: Haque T; Amlot P L; Helling N; Thomas J A; Sweny P; Rolles K; Burroughs A K; Prentice H G; Crawford D H
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6204-9.
1998: Perera S M; Thomas J A; Burke M; Crawford D H
Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
The Journal of pathology 1998;184(2):177-84.
1998: Haque T; Crawford D H
Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
Springer seminars in immunopathology 1998;20(3-4):375-87.
1997: Haque T; Crawford D H
PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material.
The Journal of general virology 1997;78 ( Pt 12)():3357-60.
1997: Haque T; Thomas J A; Parratt R; Hunt B J; Yacoub M H; Crawford D H
A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
Transplantation 1997;64(7):1028-34.
1997: Nicholson L J; Hopwood P; Johannessen I; Salisbury J R; Codd J; Thorley-Lawson D; Crawford D H
Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells.
Oncogene 1997;15(3):275-83.
1996: Haque T; Thomas J A; Falk K I; Parratt R; Hunt B J; Yacoub M; Crawford D H
Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients.
The Journal of general virology 1996;77 ( Pt 6)():1169-72.
1996: Haque T; Iliadou P; Hossain A; Crawford D H
Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.
Journal of medical virology 1996;48(1):17-21.
1995: Crawford D H; Thomas J A; Gregory C D; Catovsky D; Chaggar K
Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(5):747-53.
1995: Karimi L; Crawford D H; Speck S; Nicholson L J
Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus.
The Journal of general virology 1995;76 ( Pt 4)():759-65.
1994: Lam K M; Whittle H; Grzywacz M; Crawford D H
Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients.
Immunology 1994;82(3):383-8.
1994: Crawford D H; Chen S; Boyd C A
Cationic amino acid transport in human T lymphocytes is markedly increased in the CD45RA, CD8+ population after activation.
Immunology 1994;82(3):357-60.
1994: Doyle M G; Crawford D H
Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Intervirology 1994;37(5):236-44.
1993: Doyle M G; Catovsky D; Crawford D H
Infection of leukaemic B lymphocytes by Epstein Barr virus.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(11):1858-64.
1993: Luxton J C; Williams I; Weller I; Crawford D H
Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment.
AIDS (London, England) 1993;7(10):1337-43.
1993: Crawford D H; Catovsky D
In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Immunology 1993;80(1):40-4.
1993: Hotchin N A; Wedderburn N; Roberts I; Thomas J A; Bungey J A; Naylor B; Crawford D H
Analysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene.
British journal of cancer 1993;67(5):926-32.
1993: Allday M J; Crawford D H; Thomas J A
Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
The Journal of general virology 1993;74 ( Pt 3)():361-9.
1992: Crawford D H
Epstein-Barr virus: does it cause cancer?
The Journal of tropical medicine and hygiene 1992;95(4):229-38.
1991: Lam K M; Syed N; Whittle H; Crawford D H
Circulating Epstein-Barr virus-carrying B cells in acute malaria.
Lancet 1991;337(8746):876-8.
1991: Lam K M; Crawford D H
The oncogenic potential of Epstein-Barr virus.
Critical reviews in oncogenesis 1991;2(3):229-45.

Sign-in to see more